Revelation Biosciences (REVB) News Today → Elon Musk’s Next Move Will Disrupt AI Forever (From InvestorPlace) (Ad) Free REVB Stock Alerts $1.84 -0.22 (-10.68%) (As of 05/13/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 10, 2024 | investorplace.comREVB Stock Earnings: Revelation Biosciences Misses EPS for Q1 2024May 10, 2024 | businesswire.comRevelation Biosciences, Inc. Announces Financial Results for the Three Months Ended March 31, 2024March 22, 2024 | businesswire.comRevelation Biosciences, Inc. Announces Financial Results for the Three and Twelve Months Ended December 31, 2023March 13, 2024 | finance.yahoo.comRevelation Biosciences Inc. Gives Oral Presentation at Advances in Critical Care Nephrology (AKI & CRRT 2024)March 4, 2024 | finance.yahoo.comRevelation Biosciences Inc. Announces Commencement of First in Human Phase 1 Clinical Study of GeminiFebruary 13, 2024 | finance.yahoo.comRevelation Biosciences Inc. Receives Invitation to Give an Oral Presentation at The 29th International Conference on Advances in Critical Care Nephrology (AKI & CRRT 2024)February 9, 2024 | msn.comRevelation Biosciences Secures $6.2M in Public OfferingFebruary 5, 2024 | finance.yahoo.comRevelation Biosciences Inc. Announces Closing of $6.2 Million Public OfferingFebruary 5, 2024 | marketbeat.comTrading was temporarily halted for "REVB" at 02:02 PM with a stated reason of "LULD pause." Trading set to resume at 02:02 PM. February 2, 2024 | marketwatch.comRevelation Biosciences Shares Slide Premarket on Public OfferingFebruary 1, 2024 | msn.comRevelation Biosciences to raise ~$6.2M through public offering of sharesFebruary 1, 2024 | investorplace.comWhy Is Revelation Biosciences (REVB) Stock Down 62% Today?January 31, 2024 | marketbeat.comTrading was temporarily halted for "REVB" at 09:01 AM with a stated reason of "LULD pause."January 31, 2024 | marketbeat.comTrading was temporarily halted for "REVB" at 09:01 AM with a stated reason of "LULD pause."January 31, 2024 | marketbeat.comTrading was temporarily halted for "REVB" at 09:01 AM with a stated reason of "LULD pause."January 30, 2024 | finance.yahoo.comRevelation Biosciences Inc. to Present at The International Conference on Advances in Critical Care Nephrology (AKI & CRRT 2024)January 29, 2024 | seekingalpha.comFATE, NEXI and INBS among mid-day moversJanuary 29, 2024 | marketbeat.comTrading was temporarily halted for "REVB" at 11:01 AM with a stated reason of "LULD pause." Trading set to resume at 11:01 AM. January 29, 2024 | marketbeat.comTrading was temporarily halted for "REVB" at 10:01 AM with a stated reason of "LULD pause." Trading set to resume at 11:01 AM. January 29, 2024 | marketbeat.comTrading was temporarily halted for "REVB" at 10:01 AM with a stated reason of "LULD pause."January 29, 2024 | marketbeat.comTrading was temporarily halted for "REVB" at 10:01 AM with a stated reason of "LULD pause."January 29, 2024 | marketbeat.comTrading was temporarily halted for "REVB" at 10:01 AM with a stated reason of "LULD pause." Trading set to resume at 10:01 AM. January 29, 2024 | marketbeat.comTrading was temporarily halted for "REVB" at 09:01 AM with a stated reason of "LULD pause."January 29, 2024 | marketbeat.comTrading was temporarily halted for "REVB" at 09:01 AM with a stated reason of "LULD pause."January 29, 2024 | marketbeat.comTrading was temporarily halted for "REVB" at 09:01 AM with a stated reason of "LULD pause."January 26, 2024 | finance.yahoo.comREVB Continues March to TrialsJanuary 25, 2024 | marketbeat.comTrading was temporarily halted for "REVB" at 07:01 PM with a stated reason of "News pending."January 23, 2024 | finance.yahoo.comRevelation Biosciences Inc. Announces 1-for-30 Reverse Stock Split Effective January 25, 2024November 22, 2023 | morningstar.comRevelation Biosciences Inc Ordinary Shares REVBNovember 14, 2023 | finance.yahoo.comREVB Releases Earnings and Prepares for TrialsNovember 14, 2023 | msn.comRevelation Biosciences GAAP EPS of -$0.42November 13, 2023 | finance.yahoo.comRevelation Biosciences, Inc. Announces Financial Results for the Three and Nine Months Ended September 30, 2023October 12, 2023 | finance.yahoo.comGemini Induces Pharmacologic Activity and Related Physiologic Changes in Multiple Preclinical StudiesOctober 4, 2023 | finance.yahoo.comRevelation Biosciences, Inc. to Present at the 2023 ROTH Healthcare Opportunities ConferenceOctober 2, 2023 | finance.yahoo.comRevelation Biosciences Inc. Announces Appointment of Lakhmir Chawla, M.D. to Board of DirectorsAugust 14, 2023 | finance.yahoo.comREVB Reports Solid Balance Sheet and Remains on TrackAugust 11, 2023 | finance.yahoo.comRevelation Biosciences Inc. Announces Financial Results for the Three and Six Months Ended June 30, 2023June 29, 2023 | finance.yahoo.comREMINDER: Revelation Biosciences, Inc. Urges All Stockholders to Vote at the 2023 Annual Meeting of StockholdersJune 22, 2023 | finance.yahoo.comREVB: REVB Looks Attractive Ahead of TrialsJune 12, 2023 | finance.yahoo.comRevelation Biosciences Inc. Announces Adjournment of 2023 Annual Meeting of Stockholders to July 7, 2023 and Additional ProposalJune 6, 2023 | finance.yahoo.comREVB - Revelation Biosciences, Inc.May 22, 2023 | seekingalpha.comRevelation Biosciences GAAP EPS of $1.96May 22, 2023 | finance.yahoo.comRevelation Biosciences Inc. Announces Financial Results for the Three Months Ended March 31, 2023 and Recent Corporate ProgressMarch 30, 2023 | finance.yahoo.comRevelation Biosciences Inc. Announces Financial Results for the Three and Twelve Months Ended December 31, 2022 and Recent Corporate ProgressMarch 30, 2023 | seekingalpha.comREVB Revelation Biosciences, Inc.March 6, 2023 | finance.yahoo.comRevelation Biosciences Inc. to Participate in a Fireside Chat at the 35th Annual Roth ConferenceFebruary 9, 2023 | msn.comWhy Revelation Biosciences Is Trading 40% Lower ThursdayFebruary 9, 2023 | finance.yahoo.comRevelation Biosciences Inc. Announces Pricing of $15.6 Million Public OfferingFebruary 7, 2023 | uk.news.yahoo.comInsiders who bought in the last 12 months lose an additional US$99k as Revelation Biosciences, Inc. (NASDAQ:REVB) drops to US$5.8mFebruary 7, 2023 | bbc.co.ukThe Prophet Muhammad’s revelation Get Revelation Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for REVB and its competitors with MarketBeat's FREE daily newsletter. Email Address The Crypto 9-5 Escape Plan (Ad)A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market. Click here to get instant access to the guide REVB Media Mentions By Week REVB Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. REVB News Sentiment▼1.580.57▲Average Medical News Sentiment REVB News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. REVB Articles This Week▼40▲REVB Articles Average Week Get Revelation Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for REVB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: GeoVax Labs News Today Evoke Pharma News Today Phio Pharmaceuticals News Today Atreca News Today Ensysce Biosciences News Today Longeveron News Today Artelo Biosciences News Today Soligenix News Today Exicure News Today Tharimmune News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:REVB) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersGuard Against the Coming Financial UpheavalPorter & CompanyClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaElon’s New Device is About to Shock the WorldInvestorPlaceCharles Payne Demystifies OptionsUnstoppable ProsperityThe only AI company you should be looking atBehind the MarketsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Revelation Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
